Photodynamic Therapy and Cardiovascular Diseases.
Aleksander OskrobaDorota Bartusik-AebisherAngelika MyśliwiecKlaudia DynarowiczGrzegorz CieślarAleksandra Kawczyk-KrupkaDavid AebisherPublished in: International journal of molecular sciences (2024)
Cardiovascular diseases are the third most common cause of death in the world. The most common are heart attacks and stroke. Cardiovascular diseases are a global problem monitored by many centers, including the World Health Organization (WHO). Atherosclerosis is one aspect that significantly influences the development and management of cardiovascular diseases. Photodynamic therapy (PDT) is one of the therapeutic methods used for various types of inflammatory, cancerous and non-cancer diseases. Currently, it is not practiced very often in the field of cardiology. It is most often practiced and tested experimentally under in vitro experimental conditions. In clinical practice, the use of PDT is still rare. The aim of this review was to characterize the effectiveness of PDT in the treatment of cardiovascular diseases. Additionally, the most frequently used photosensitizers in cardiology are summarized.
Keyphrases
- photodynamic therapy
- cardiovascular disease
- fluorescence imaging
- cardiovascular risk factors
- clinical practice
- cardiovascular events
- atrial fibrillation
- type diabetes
- randomized controlled trial
- systematic review
- papillary thyroid
- squamous cell carcinoma
- acute kidney injury
- oxidative stress
- coronary artery disease
- combination therapy
- squamous cell
- subarachnoid hemorrhage